Published in J Mol Biol on October 29, 1999
POVME: an algorithm for measuring binding-pocket volumes. J Mol Graph Model (2010) 1.75
Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment. J Mol Biol (2007) 0.89
QM/MM linear response method distinguishes ligand affinities for closely related metalloproteins. Proteins (2007) 0.87
Binding affinity of hydroxamate inhibitors of matrix metalloproteinase-2. J Mol Model (2004) 0.86
Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10. J Comput Aided Mol Des (2003) 0.83
Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3. Biophys J (2010) 0.83
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion. Biochem J (2007) 0.81
Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors. J Biol Inorg Chem (2007) 0.79
An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors. PLoS One (2012) 0.77
A multidisciplinary approach to probing enthalpy-entropy compensation and the interfacial mobility model. J Am Chem Soc (2011) 0.77
Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14. J Biol Chem (2016) 0.75
Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease. Dig Dis Sci (2007) 0.75
An endosomal beta COP is involved in the pH-dependent formation of transport vesicles destined for late endosomes. J Cell Biol (1996) 2.94
Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell (1999) 2.89
PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic. EMBO J (2001) 2.26
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage (2001) 1.42
Fungal virus capsids, cytoplasmic compartments for the replication of double-stranded RNA, formed as icosahedral shells of asymmetric Gag dimers. J Mol Biol (1994) 1.39
The open conformation of a Pseudomonas lipase. Structure (1997) 1.39
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab (2014) 1.29
Lipids, lipid domains and lipid-protein interactions in endocytic membrane traffic. Semin Cell Dev Biol (1998) 1.29
Revised 2.3 A structure of porcine pepsin: evidence for a flexible subdomain. Proteins (1990) 1.16
CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene (2012) 1.12
Demonstration of a dynamic, transcription-dependent organization of pre-mRNA splicing factors in polytene nuclei. J Cell Biol (1996) 1.04
Directed evolution of a subtilisin with calcium-independent stability. Biotechnology (N Y) (1995) 0.99
Patterned orocutaneous therapy improves sucking and oral feeding in preterm infants. Acta Paediatr (2008) 0.98
Differences between bisphosphonates in binding affinities for hydroxyapatite. J Biomed Mater Res B Appl Biomater (2010) 0.96
Survival, mutagenesis, and host cell reactivation in a Chinese hamster ovary cell ERCC1 knock-out mutant. Mutagenesis (1997) 0.96
cDNA sequence and chromosome localization of pig alpha 1,3 galactosyltransferase. Immunogenetics (1995) 0.93
Human D-Phe-Pro-Arg-CH2-alpha-thrombin crystallization and diffraction data. J Mol Biol (1989) 0.92
Massive lipoma of the scrotum. Chin Med J (Engl) (1999) 0.90
Mutations in both sides of the photosystem I reaction center identify the phylloquinone observed by electron paramagnetic resonance spectroscopy. J Biol Chem (2001) 0.89
High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf) (2013) 0.89
Design and synthesis of piperazine-based matrix metalloproteinase inhibitors. J Med Chem (2000) 0.88
Structure of a pepsin/renin inhibitor complex reveals a novel crystal packing induced by minor chemical alterations in the inhibitor. Acta Crystallogr B (1992) 0.88
Discovery of potent, achiral matrix metalloproteinase inhibitors. J Med Chem (1998) 0.88
Gene 5 protein-DNA complex: modeling binding interactions. J Biomol Struct Dyn (1990) 0.88
When the transesophageal echo probe goes into the trachea. J Cardiothorac Vasc Anesth (1999) 0.86
Polymorphisms in genes involved in DNA repair, cell growth, oxidative stress and inflammatory response, and melanoma risk. Br J Dermatol (2009) 0.85
[Chronic active hepatitis with superinfection of delta virus and hepatitis B virus: treatment with Chinese traditional medicine]. Zhonghua Nei Ke Za Zhi (1990) 0.85
Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors. J Med Chem (1999) 0.85
Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation. J Biol Chem (1998) 0.85
Dynamic process of information transmission complexity in human brains. Biol Cybern (2000) 0.84
Effects of engineered salt bridges on the stability of subtilisin BPN'. Protein Eng (1990) 0.84
Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines. J Med Chem (2000) 0.84
Measurement of 129 I and 137 Cs in soils from Belarus and reconstruction of 131I deposition from the Chernobyl accident. Health Phys (2006) 0.84
Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations. Histopathology (2008) 0.83
A new look at the consultation continuum. J Fam Pract (1977) 0.82
The post-suicide family and the family physician. J Fam Pract (1976) 0.82
In situ hybridization mapping and restriction fragment length polymorphism analysis of the porcine albumin (ALB) and transferrin (TF) genes. Anim Genet (1993) 0.82
Genetic analysis of the gene for porcine submaxillary gland mucin: physical assignment of the MUC and interferon gamma genes to chromosome 5. J Hered (1993) 0.80
Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold. J Med Chem (1999) 0.80
Laundry performance of subtilisin proteases. Adv Exp Med Biol (1996) 0.79
Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis. Inflamm Res (2006) 0.79
Inhibitor binding induces structural changes in porcine pepsin. Adv Exp Med Biol (1991) 0.79
The structure of prothrombin fragment 1 at 3.5-A resolution. J Biol Chem (1985) 0.79
Design and synthesis of conformationally-constrained MMP inhibitors. Bioorg Med Chem Lett (1998) 0.78
Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry. Hum Pathol (1992) 0.78
Fluorescent Detection of Oral Pathogens by a Solid-Phase Immunoassay on PDMS. Conf Proc IEEE Eng Med Biol Soc (2005) 0.78
Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity. Biochemistry (1996) 0.78
Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases. J Med Chem (2001) 0.78
Crystallization and preliminary diffraction data of Escherichia coli ADP glucose pyrophosphorylase. J Biol Chem (1988) 0.78
[Effect of tongxinluo capsule in treating variant angina pectoris patients and its influence on endothelial function]. Zhongguo Zhong Xi Yi Jie He Za Zhi (1999) 0.78
Mapping of the interferon gamma (IFNG) gene in river and swamp buffaloes by in situ hybridization. Hereditas (1994) 0.78
[Proliferation and apoptosis status in benign prostatic hyperplasia]. Zhonghua Wai Ke Za Zhi (1996) 0.77
Assignment of the linkage group EAM-TYRP2-TPP2 to chromosome 11 in pigs by in situ hybridization mapping of the TPP2 gene. Chromosome Res (1993) 0.77
The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold. Bioorg Med Chem Lett (2001) 0.77
A pseudoautosomal minisatellite in the pig. Mamm Genome (1994) 0.77
The next generation of MMP inhibitors. Design and synthesis. Ann N Y Acad Sci (1999) 0.77
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. J Nucl Med (1980) 0.77
Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1. Chin Med J (Engl) (1998) 0.77
Recognizing borderline personality disorder in the family practice setting. Am Fam Physician (1995) 0.76
[Effects of neonatal administration of monosodium glutamate on acupuncture analgesia and beta-endorphin-immunoreactive neurons in the rat hypothalamic arcuate nucleus]. Zhen Ci Yan Jiu (1987) 0.76
Environmental nicotine contamination in latent fingermarks from smoker contacts and passive smoking. Forensic Sci Int (2010) 0.76
Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer. Chin Med J (Engl) (2000) 0.76
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines. J Med Chem (2001) 0.76
Peptide mimetics of the thrombin-bound structure of fibrinopeptide A. Proc Natl Acad Sci U S A (1992) 0.76
Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases. J Med Chem (1999) 0.75
Molecular modeling of the structures of human and rat pancreatic cholesterol esterases. Protein Sci (1997) 0.75
Heterocycle-based MMP inhibitors with P2' substituents. Bioorg Med Chem Lett (2001) 0.75
Application of LC-NMR and LC-MS to the identification of degradation products of a protease inhibitor in dosage formulations. J Pharm Biomed Anal (1999) 0.75
[Sequencing of right terminal fragment of canine adenovirus type 1 vaccine strain DNA]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (1996) 0.75
[Study on psychoprophylaxis and monoamines neurotransmitter of patients with burning mouth syndrome]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 0.75
[Apoptosis in the early stage of compensatory renal growth following uninephrectomy in the young and old rats]. Zhonghua Yi Xue Za Zhi (1997) 0.75
[Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax]. Zhonghua Wai Ke Za Zhi (1998) 0.75
[Experimental study on increasing arterial oxygen saturation by healthy exerciser under hypoxia]. Space Med Med Eng (Beijing) (1997) 0.75
[In situ hybridization to detect the mRNA for insulin-like growth factor-I and II in the prostate]. Zhonghua Wai Ke Za Zhi (1996) 0.75
Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction. Chin Med J (Engl) (1997) 0.75
Generalized dimension of the intersection between EEGs. Biol Cybern (2001) 0.75
[Changes of nitric oxide synthase in the brain induced by X-ray in mice]. Zhongguo Ying Yong Sheng Li Xue Za Zhi (1997) 0.75
Rapid analysis of single-cysteine variants of recombinant proteins. Methods Mol Biol (1996) 0.75
[Preparation and characterization of human monoclonal antibody to breast carcinoma]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (1996) 0.75
[Histologic examination and immunohistochemical analysis of estrogen and progesterone receptors of eutopic and ectopic endometrium in patients with endometriosis]. Zhonghua Fu Chan Ke Za Zhi (1996) 0.75
[IL-6 gene expression in human tumor cell lines]. Zhonghua Wai Ke Za Zhi (1996) 0.75
[Quantitative determination of ginsenoside Rg1 in Capsulae gansuning by TLC-scanning]. Zhongguo Zhong Yao Za Zhi (1996) 0.75
Clinical and experimental observations of peripheral blood leukocytes and nucleated bone marrow cells after local irradiation. Minerva Med (2013) 0.75
[Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines]. Zhonghua Wai Ke Za Zhi (1996) 0.75